Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Endometrial Cancer
Would you offer consolidative radiation for oligometastatic uterine serous CA s/p surgery and chemotherapy with complete response?
Answer from: Radiation Oncologist at Community Practice
Usually not unless pelvis only confined disease at presentation or microscopic omental disease removed at surgery.
Comments
Radiation Oncologist at East Alabama Medical Center
Surgically pT3pN0 but on post op staging found to ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Was bone Mets bx proven?
Radiation Oncologist at East Alabama Medical Center
Unfortunately no, but PET avid and distinct lesion...
5004
5005
5008
Sign in or Register to read more
10819
Related Questions
Would you offer systemic chemotherapy to a patient with at least 2023 FIGO stage IC high grade serous (p53-mut) endometrial cancer with extensive LVI for whom nodal assessment was not done?
Would you treat with extended field pelvic radiation for a patient with FIGO IIIC1 endometrial cancer who was found with isolated tumor cells (ITCs) on a single paraaortic sentinel lymph node?
What adjuvant treatment would you recommend for a patient with FIGO 2023 IIIB2 endometrioid endometrial adenocarcinoma (Grade 3, p53mut, MMR proficient), metastatic to the uterine serosa, bilateral ovaries, and anterior peritoneal reflection?
Given the negative results of GOG-0238 but the positive results of the RUBY trial, how do you manage isolated vaginal cuff recurrence of endometrial cancer?
How would you sequence adjuvant chemo-immunotherapy (paclitaxel/carbo/pembro or paclitaxel/carbo/dostarlimab) with EBRT and vaginal cuff brachytherapy in advanced uterine cancer that meets clinical criteria for both EBRT and chemo-IO?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?
What dose would you use to treat unresectable basal cell carcinoma of the vulva?
How do you counsel patients about prognosis with FIGO 2018 IIIC cervix cancer managed in the new era of chemoradiation plus immunotherapy?
How would you manage a female in her 40s with stage III cervical cancer with hydronephrosis and Crohn's disease?
Surgically pT3pN0 but on post op staging found to ...
Was bone Mets bx proven?
Unfortunately no, but PET avid and distinct lesion...